A known structural component of gram-negative bacteria, endotoxins can elicit strong inflammatory responses and fever if they enter the human bloodstream.

We have evaluated the use of rapidly growing mycobacterium (RGM) media in disinfection efficacy studies and shown its capacity to improve the accuracy of studies regarding undesirable contaminants.

Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Choosing the right partner-with expertise in antibody and tissue selection, cutoff design and regulatory approvals-is key to advancing global CDx programs.

Biocompatibility evaluation endpoints chart

Accelerated aging testing sample submission form

Microbiology related testing sample submission form

ACT 2023 -- Safety assessment of pharmaceuticals and chemicals with potential for repeated human exposure involves determining toxicity in studies that align with country-specific regulatory frameworks.

Liquid biopsies represent a transformation in the management of cancer as they have the potential to detect, characterize, and monitor cancers earlier than conventional diagnostic modalities.